Literature DB >> 16495561

Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate.

Kris I Orsborn1, Lisa F Shubitz, Tao Peng, Ellen M Kellner, Marc J Orbach, Paul A Haynes, John N Galgiani.   

Abstract

Coccidioides posadasii and Coccidioides immitis are dimorphic, soil-dwelling pathogenic ascomycetes endemic to the southwestern United States. Infection can result from inhalation of a very few arthroconidia, but following natural infection, long-lived immunity is the norm. Previous work in the field has shown that spherule-derived vaccines afford more protection than those from mycelia. We have used two-dimensional differential in-gel electrophoresis coupled with nano-high-performance liquid chromatography-tandem mass spectrometry to directly assess both absolute abundance and differential expression of proteins in the spherule and the mycelial phases of C. posadasii with the intent to identify potential vaccine candidates. Peptides derived from 40 protein spots were analyzed and a probable identity was assigned to each. One spherule-abundant protein, identified as Pmp1, showed homology to allergens from Aspergillus fumigatus and other fungi, all of which exhibit similarity to yeast thiol peroxidases. Recombinant Pmp1 was reactive with serum from individuals with both acute and protracted disease, and evoked protection in two murine models of infection with C. posadasii. These results demonstrate the utility of proteomic analysis as a point of discovery for protective antigens for possible inclusion in a vaccine candidate to prevent coccidioidomycosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495561      PMCID: PMC1418667          DOI: 10.1128/IAI.74.3.1865-1872.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  Moonlighting proteins: old proteins learning new tricks.

Authors:  Constance J Jeffery
Journal:  Trends Genet       Date:  2003-08       Impact factor: 11.639

2.  Cytokine production by peripheral blood mononuclear cells in human coccidioidomycosis.

Authors:  D B Corry; N M Ampel; L Christian; R M Locksley; J N Galgiani
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

3.  NUTRITION OF THE PARASITIC PHASE OF COCCIDIOIDES IMMITIS IN A CHEMICALLY DEFINED LIQUID MEDIUM.

Authors:  J L Converse; A R Besemer
Journal:  J Bacteriol       Date:  1959-08       Impact factor: 3.490

4.  Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.

Authors:  C R Zimmermann; S M Johnson; G W Martens; A G White; B L Zimmer; D Pappagianis
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Involvement of the major glycoprotein (gp43) of Paracoccidioides brasiliensis in attachment to macrophages.

Authors:  S R Almeida; C S Unterkircher; Z P Camargo
Journal:  Med Mycol       Date:  1998-12       Impact factor: 4.076

6.  Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry.

Authors:  M Wilm; A Shevchenko; T Houthaeve; S Breit; L Schweigerer; T Fotsis; M Mann
Journal:  Nature       Date:  1996-02-01       Impact factor: 49.962

7.  Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential.

Authors:  K O Dugger; K M Villareal; A Ngyuen; C R Zimmermann; J H Law; J N Galgiani
Journal:  Biochem Biophys Res Commun       Date:  1996-01-17       Impact factor: 3.575

8.  Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity.

Authors:  Ashraf S Ibrahim; Brad J Spellberg; Valentina Avenissian; Yue Fu; Scott G Filler; John E Edwards
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 9.  Serology of coccidioidomycosis.

Authors:  D Pappagianis; B L Zimmer
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

10.  Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.

Authors:  Chengyong Jiang; D Mitchell Magee; F Douglas Ivey; Rebecca A Cox
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  20 in total

1.  Differences in Host Innate Responses among Coccidioides Isolates in a Murine Model of Pulmonary Coccidioidomycosis.

Authors:  Eric R G Lewis; Victoria R David; Adina L Doyle; Khadijeh Rajabi; Jeffrey A Kiefer; Patrick Pirrotte; Bridget M Barker
Journal:  Eukaryot Cell       Date:  2015-08-14

2.  Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis.

Authors:  James I Ito; Joseph M Lyons; Teresa B Hong; Daniel Tamae; Yi-Kuang Liu; Sharon P Wilczynski; Markus Kalkum
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

3.  Vaccines to prevent systemic mycoses: holy grails meet translational realities.

Authors:  John N Galgiani
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

Review 4.  A review of innate and adaptive immunity to coccidioidomycosis.

Authors:  Chiung-Yu Hung; Amy P Hsu; Steven M Holland; Joshua Fierer
Journal:  Med Mycol       Date:  2019-02-01       Impact factor: 4.076

5.  Multivalent recombinant protein vaccine against coccidioidomycosis.

Authors:  Eric J Tarcha; Venkatesha Basrur; Chiung-Yu Hung; Malcolm J Gardner; Garry T Cole
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

6.  CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine.

Authors:  Diana Diaz-Arevalo; Karine Bagramyan; Teresa B Hong; James I Ito; Markus Kalkum
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

Review 7.  Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.

Authors:  Chinh Nguyen; Bridget Marie Barker; Susan Hoover; David E Nix; Neil M Ampel; Jeffrey A Frelinger; Marc J Orbach; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

8.  Immune responses induced by heat killed Saccharomyces cerevisiae: a vaccine against fungal infection.

Authors:  Min Liu; Karl V Clemons; Marty Bigos; Izabela Medovarska; Elmer Brummer; David A Stevens
Journal:  Vaccine       Date:  2011-01-08       Impact factor: 3.641

9.  Healthy human T-Cell Responses to Aspergillus fumigatus antigens.

Authors:  Neelkamal Chaudhary; Janet F Staab; Kieren A Marr
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

10.  Histoplasma capsulatum proteome response to decreased iron availability.

Authors:  Michael S Winters; Daniel S Spellman; Qilin Chan; Francisco J Gomez; Margarita Hernandez; Brittany Catron; Alan G Smulian; Thomas A Neubert; George S Deepe
Journal:  Proteome Sci       Date:  2008-12-24       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.